Women Deserve Better - Survivors Deserve Better
BreastDefense aims to be 99% accurate and will identify invasive breast cancers, at any stage, from stage one through four. BreastDefense will be able to distinguish benign cells from those containing invasive breast cancer. BreastDefense aims to achieve the same degree of accuracy in monitoring remission.
Once breast cancer treatments are completed, survivors want to monitor remission.
It can be a time of worry for women who fear the cancer could come back.
BreastDefense, an easy and accurate blood test will put these fears at bay. It will eliminate the need for inaccurate tests that can do more harm than good.